AGP Executive Report
Last update: an hour agoVaccine Research: Guinea-Bissau has cancelled a proposed US-funded hepatitis B vaccine trial involving 14,000 newborns after an ethics backlash. The study planned to delay the birth-dose vaccine for half the babies, despite WHO guidance to give it within 24 hours. The health minister said the government had not approved the study, and police seized vaccines from the Bandim Health Project research centre. Digital Trade: An ECOWAS parliamentary mission has urged wider use of SIGMAT, a digital customs platform designed to track goods in transit and cut delays. The review in Liberia highlighted barriers including poor roads, limited connectivity and a need for more training.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.